Searched for
PHARMA PACKAGING
Mold-TekPackagingsharessurge17% as Q2FY27profitjumps35% YoY to Rs21croreMold-Tek Packaging shares surged nearly 17% after the company reported a 35.5% YoY rise in Q2 FY27 net profit and 30.5% revenue growth. Str...- Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: ReportIndian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...
- These large-, mid- and small-cap stocks can give more than 20% return in 1 year, according to analystsHere’s one thing that is worth clarifying, because it is in the headlines. Large global technology companies have been announcing heavy spe...
- PM Modi reviews projects worth over Rs 16,000 crore across 31 States, UTs at 54th PRAGATI meetingPrime Minister Narendra Modi chaired the 54th PRAGATI meeting to evaluate infrastructure projects worth over Rs 16,000 crore. The meeting f...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhen a market is as jittery as it is right now, poor numbers are treated harshly. A new-age company in the business of buying and selling u...
- India to remain top of the Asian pie for AdventAdvent International has successfully raised $30 billion for its global buyout and mid-market funds. The firm plans to invest significantly...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsAt this juncture, what companies say about their Q2 results, and their outlook for Q3 and Q4, matters a great deal – but only to a certain ...
- Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruptionDr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...
- FMCG stocks lost their tag of defensive stocks, will they get it back? 7 FMCG stocks with an upside potential of up to 32%Those who have been following the market for long know this: When there is nervousness on the street, money instinctively moves towards a p...
- No love for the middle: CPHI Milan exposes India’s pharma scaling challengeIndian pharma and chemical companies at CPHI Milan say the China+1 opportunity is real, but a “missing middle” in the MSME ecosystem, marke...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%A piece of advice for those who still have the stomach to invest in the current volatile market. Don’t take any price action as the gospel ...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Healthcare paradox: More access, but who pays?Scaling too fast is irrelevant. The real problem is that India still confuses more hospitals, more doctors and more medicines with better h...
- GST Council meeting 2026: What may change as GST 2.0 takes aim at ITC, refunds, arrest powers and other reformsGST Council Meeting 2026: The GST Council, meeting in New Delhi, is expected to propose significant reforms for tax administration. One ref...
- Maharashtra FDA cancels Cipla's Pune warehouse licences over Reactin Plus packaging claimsMaharashtra's Food and Drug Administration has cancelled Cipla Pharma's distribution licenses due to serious violations. The FDA discovered...
- Nifty valuations near post-Covid lows. Alchemy Capital’s Alok Agarwal explains what investors should buy nowNifty valuations have reset sharply from 2024 levels and are now near post-Covid lows, says Alchemy Capital’s Alok Agarwal. He sees the nex...
- Fortis, Apollo, other hospital stocks slump up to 10% in 2 days after SC questions steep markups. Buying opportunity?Hospital stocks extended losses for a second session after the Supreme Court questioned steep markups on cancer drugs and raised concerns o...
- New indicator for New India: 25 stocks whose numbers can reveal what is in store for the economy and the stock marketFor decades, there was a familiar way to understand the Indian consumer. Economists waited for GDP, industrial production, inflation, credi...
- 94% of packaged foods may face warnings under nutrient limits; FSSAI ex-chief Pawan Kumar Agarwal urges SC for phased food warning rolloutFormer FSSAI chief Pawan Kumar Agarwal has urged the Supreme Court to consider a phased rollout of front-of-pack food warnings, warning tha...
- Munde’s action wins public praise, but court rebukes FDA over processFDA Commissioner Tukaram Mundhe faces criticism after initial praise for regulatory actions. The Bombay High Court has repeatedly pulled up...
Load More
